Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (17)

1

Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer : A Systematic Review and Meta-analysis

enthalten in: Current cancer drug targets | 2024

von Zheng, B. | He, M. | Han, Y. | +12

2

Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer : A Systematic Review and Meta-analysis of Randomized Controlled Trials

enthalten in: Current cancer drug targets | 2024

von Wang, Y. | Du, X. | Xin, H. | +1

3

Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer : A Systematic Review and Network Meta-analysis

enthalten in: Current cancer drug targets | 2023

von Wang, T. | Shen, G. | Li, J. | +6

4

The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer : A Systematic Review and Meta-Analysis

enthalten in: Current cancer drug targets | 2021

von Ganbat, D. | Jugder, B. | Ganbat, L. | +6

5

The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis

enthalten in: Current cancer drug targets | 2021

von Ganbat, D. | Jugder, B. | Ganbat, L. | +6

6

Prognostic Value of MiRNAs in Patients with Laryngeal Cancer : A Systematic Review and Meta-Analysis

enthalten in: Current cancer drug targets | 2020

von Zou, W. | Hu, X. | Wang, D. | +1

7

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer : A Systematic Review and Meta-analysis

enthalten in: Current cancer drug targets | 2019

von Yan, B. | Cong, X. | Zhao, S. | +5

8

Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety

enthalten in: Current cancer drug targets | 2019

von Wang, M. | Wang, G. | Ma, H. | +1

9

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

enthalten in: Current cancer drug targets | 2019

von Yan, B. | Cong, X. | Zhao, S. | +5

10

Crizotinib Versus Chemotherapy on ALK-positive NSCLC : A Systematic Review of Efficacy and Safety

enthalten in: Current cancer drug targets | 2019

von Wang, M. | Wang, G. | Ma, H. | +1